Urinary free metanephrines for diagnosis of pheochromocytoma and paraganglioma

8Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Background: Pheochromocytoma and paraganglioma (PPGL) is diagnosed through biochemical confirmation of excessive catecholamines in urine and plasma. Recent technological developments have allowed us to measure urinary free metanephrines; however, the diagnostic accuracy of these new methods and the diagnostic cutoff values have not been evaluated. Methods: This is a retrospective study of 595 subjects, including 71 PPGL cases and 524 controls. PPGL was based on pathological confirmation. Subjects with no evidence of PPGL over 2 years were included in the control group. Results: Urinary free metanephrines yielded similar area under the curve (AUC) to urinary fractionated metanephrines and plasma free metanephrines. However, urinary free normetanephrine yielded a better AUC than did urinary fractionated normetanephrine. The optimal cutoff for urinary free metanephrine and normetanephrine corrected for urinary creatinine yielded 97.2% sensitivity and 98.1% specificity. Conclusion: Urinary free metanephrines are a reliable method for diagnosing PPGL in Asian populations compared with existing biochemical methods.

Cite

CITATION STYLE

APA

Ahn, J., Park, J. Y., Kim, G., Jin, S. M., Hur, K. Y., Lee, S. Y., & Kim, J. H. (2021). Urinary free metanephrines for diagnosis of pheochromocytoma and paraganglioma. Endocrinology and Metabolism, 36(3), 697–701. https://doi.org/10.3803/ENM.2020.925

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free